Denis A. Babkov

Structural modifications of 2,3-indolobetulinic acid: Design and synthesis of highly potent α-glucosidase inhibitors

E. F. Khusnutdinova, Anastasiya V. Petrova, Nguyễn Thị Thu Hà et al. · Bioorganic Chemistry · 2019 · 50 citations

Pharmacy, Biochemistry, Medicinal Chemistry +10

Synthesis, in vitro and in vivo evaluation of 2-aryl-4H-chromene and 3-aryl-1H-benzo[f]chromene derivatives as novel α-glucosidase inhibitors

Denis A. Babkov, Dmitry V. Osipov, Vladlen Klochkov et al. · Bioorganic & Medicinal Chemistry Letters · 2018 · 48 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +9

Towards multi-target antidiabetic agents: Discovery of biphenyl-benzimidazole conjugates as AMPK activators

Denis A. Babkov, Olga N. Zhukowskaya, V. A. Babkova et al. · Bioorganic & Medicinal Chemistry Letters · 2019 · 46 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +13

Synthesis and biological evaluation of 3-substituted 2-oxindole derivatives as new glycogen synthase kinase 3β inhibitors

Natalia A. Lozinskaya, Denis A. Babkov, Ekaterina V. Zaryanova et al. · Bioorganic & Medicinal Chemistry · 2019 · 43 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +13

6‐Nitroazolo[1,5‐<i>a</i>]pyrimidin‐7(4<i>H</i>)‐ones as Antidiabetic Agents

Denis A. Babkov, Roman Litvinov, D. D Shamshina et al. · Archiv der Pharmazie · 2017 · 41 citations

Pharmacy, Medicinal Chemistry, Pharmacology +11